|
Arotech Corporation Announces
$6.6 Million
Direct Equity Placement
Company also receives $16.5
million from exercises of outstanding warrants
July
15, 2004 - Arotech Corporation (NasdaqNM: ARTX) announced today
that it has entered into a definitive agreement with several institutional
investors for the purchase of an aggregate of 4,258,065 shares of
its common stock at $1.55 per share off of Arotech’s effective
shelf registration statement. Gross proceeds to Arotech will be
approximately $6.6 million. The proceeds of the offering will be
used primarily for the acquisition, announced today in a separate
press release, of Armour of America Incorporated.
The Company also announced that
it had previously received a total of $16.5 million upon exercise
of a total of 8,814,235 of its outstanding warrants. As part of
the consideration for their exercise, these warrant holders received
an equal number of new warrants at an exercise price to be determined
based on 90% of the variable weighted average of the price of the
Company’s common stock on the Nasdaq Stock Market over the
next three days, but not more than $1.88. The new warrants that
were issued and the shares underlying the warrants have not been
registered under the Securities Act of 1933, as amended, and may
not be offered or sold in the United States absent registration
under the Securities Act and applicable state securities or an applicable
exemption from the registration requirements of such act. Arotech
has agreed to file a registration statement covering the shares
of common stock issuable upon exercise of the new warrants.
If the acquisition of Armour of
America is for any reason not consummated, the proceeds will be
used for general corporate purposes, which may include acquisitions
or investments in businesses, products or technologies that are
complementary to the Company’s own, funding research, development
and product manufacturing, increasing the Company’s working
capital, reducing indebtedness, and capital expenditures.
This press release shall not constitute
an offer to sell or a solicitation of an offer to buy, nor shall
there be any sale of these securities in any state in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state.
About Arotech Corporation
Arotech Corporation provides quality
defense and security products for the military, law enforcement
and homeland security markets, including advanced zinc-air and lithium
batteries and chargers, multimedia interactive simulators/trainers
and lightweight vehicle armoring.
The Battery and Power Systems
Division includes Electric Fuel Battery Corporation and Epsilor
Electronic Industries. The Simulation, Training and Consulting Division
includes IES Interactive Training and FAAC Incorporated. The Armored
Vehicle Division includes MDT Armor Corp and MDT Protective Industries
Ltd.
Arotech is incorporated in Delaware,
with corporate offices in New York, and research, development and
production subsidiaries in Alabama, Colorado, Michigan and Israel.
Except for the historical information herein,
the matters discussed in this news release include forward-looking
statements, as defined in the Private Securities Litigation Reform
Act of 1995. Readers are cautioned not to place undue reliance on
these forward-looking statements, as they are subject to various
risks and uncertainties that may cause actual results to vary significantly.
These risks and uncertainties include, but are not limited to, risks
relating to: product and technology development; the uncertainty
of the market for Arotech’s products; changing economic conditions;
delay, cancellation or non-renewal, in whole or in part, of contracts
or of purchase orders; and other risk factors detailed in Arotech’s
most recent Annual Report on Form 10-K for the fiscal year ended
December 31, 2003 and other filings with the Securities and Exchange
Commission. Arotech assumes no obligation to update the information
in this release. Reference to the Company’s website above
does not constitute incorporation of any of the information thereon
into this press release.
|